RIPK1 and Cognitive impairment: Ou et al. demonstrated that BBR treatment could significantly inhibit the expression of receptor-interacting protein 1 (RIP1) and RIP3, two key regulators of necroptosis, attenuating the neuroinflammatory response and cognitive impairment in the hippocampus tissues in rats exposed to excessive L-arginine [107].